Are NeuEve products supported by clinical studies?

Third-Party Customer Survey Study

Typeform, a reputable third-party survey company trusted by brands like Apple, Airbnb, Uber, and Nike, conducted an extensive survey of NeuEve users. One month after purchasing a NeuEve product, participants received an email requesting feedback. The survey asked them to rate the severity of their symptoms before and after using NeuEve, with options ranging from very severe to no symptoms. Based on responses, Typeform generated charts to display customer feedback.

Survey Results:

1. Products for relieving vaginal dryness and atrophy

These products include NeuEve Velvet, Silk, Silver, and Gold suppositories, Salve and Salve-Gentle balms, and Feminine Moisture Support pills. The results are all highly significant.

  • NeuEve Velvet (Sensitive Silk) (Recommended for Ages Over 70)
    • Participants: N = 53
    • Before Treatment: 22.6% very severe, 52.8% severe, 24.5% moderate, 0.0% slight, 0.0% no symptoms
    • After Treatment: 5.7% very severe, 17.0% severe, 32.1% moderate, 30.2% slight, 15.1% no symptoms
    • Statistical Analysis: Chi-squared value = 39.63, P-value = 5.16e-08 (highly significant)

Velvet Effect Chart.JPG

  • NeuEve Silk (Recommended for Ages 55-70)
    • Participants: N = 1,995
    • Before Treatment: 22.9% very severe, 45.4% severe, 28.3% moderate, 2.4% slight, 1.0% no symptoms
    • After Treatment: 3.5% very severe, 14.1% severe, 30.7% moderate, 36.8% slight, 14.9% no symptoms
    • Statistical Analysis: Chi-squared value = 1,459.51, P-value < 0.001 (highly significant)

Silk Effect Chart.JPG

  • NeuEve Silver (Recommended for Ages 45-55)
    • Participants: N = 532
    • Before Treatment: 16.5% very severe, 43.0% severe, 35.5% moderate, 3.6% slight, 1.5% no symptoms
    • After Treatment: 1.5% very severe, 8.5% severe, 25.4% moderate, 45.9% slight, 18.8% no symptoms
    • Statistical Analysis: Chi-squared value = 469.1, P-value = 3.22e-100 (highly significant)

(Note: The value 3.22e-100 represents 3.22 × 10^-100, which is scientific notation for a very small number. Specifically, it means: 3.22 is multiplied by 10 raised to the power of -100. This is an extremely small number, so small that it is practically close to zero.
In the context of statistical analysis, such a small p-value (close to 0) indicates extremely strong evidence against the null hypothesis. In simpler terms, it suggests that the observed results are highly statistically significant, meaning there is a very low probability that the observed outcome is due to random chance.)

Silver Effect Chart.JPG

  • NeuEve Gold (Recommended for Ages Under 45)
    • Participants: N = 259
    • Before Treatment: 20.1% very severe, 39.0% severe, 35.9% moderate, 4.6% slight, 0.4% no symptoms
    • After Treatment: 2.7% very severe, 6.2% severe, 20.8% moderate, 42.5% slight, 27.8% no symptoms
    • Statistical Analysis: Chi-squared value = 254.39, P-value = 7.36e-54 (highly significant)

Gold Effect Chart.JPG

  • NeuEve Vulva Balm Cream (Recommended for Ages Under 70)
    • Participants: N = 182
    • Before Treatment: 21.3% very severe, 43.5% severe, 30.0% moderate, 3.4% slight, 1.6% no symptoms
    • After Treatment: 2.0% very severe, 11.2% severe, 30.2% moderate, 41.2% slight, 15.4% no symptoms
    • Statistical Analysis: Chi-squared value = 1,052.73, P-value = 1.33e-226 (highly significant)

Salve chart.JPG

  • NeuEve Salve-Gentle (Sensitive Balm Cream) (Recommended for Ages Over 70)
    • Participants: N = 44
    • Before Treatment: 27.3% very severe, 47.7% severe, 20.5% moderate, 4.5% slight, 0.0% no symptoms
    • After Treatment: 4.5% very severe, 13.6% severe, 29.5% moderate, 38.6% slight, 13.6% no symptoms
    • Statistical Analysis: Chi-squared value = 34.11, P-value = 7.09e-07 (highly significant)

Salve-Gentle Chart.JPG

  • NeuEve Feminine Moisture Support (Sea Buckthorn Oil)
    • Participants: N = 182
    • Before Treatment: 23.1% very severe, 40.1% severe, 33.0% moderate, 3.3% slight, 0.5% no symptoms
    • After Treatment: 3.3% very severe, 10.4% severe, 34.6% moderate, 35.2% slight, 16.5% no symptoms
    • Statistical Analysis: Chi-squared value = 142.50, P-value = 8.21e-30 (highly significant)

FMS Effect Chart.JPG

  • NeuEve BV Clear (Recommended for Ages Under 45) - Odor
    • Participants: N = 253
    • Before Treatment: 8.3% very severe, 23.3% severe, 33.2% moderate, 21.7% slight, 13.4% no odor
    • After Treatment: 2.0% very severe, 8.3% severe, 16.6% moderate, 25.7% slight, 47.4% no odor
    • Statistical Analysis: Chi-squared value = 90.72, P-value = 9.26e-19 (highly significant)

2. Products for clearing BV and AV

These products include BV Clear and AV Clear (AV NIL). Their effects are all highly significant.

BV Clear on odor effect chart.JPG

  • NeuEve BV Clear (Recommended for Ages Under 45) - Discharge
    • Participants: N = 253
    • Before Treatment: 4.3% very severe, 11.1% severe, 41.1% moderate, 31.6% slight, 11.9% no discharge
    • After Treatment: 1.6% very severe, 5.5% severe, 21.7% moderate, 36.0% slight, 35.2% no discharge
    • Statistical Analysis: Chi-squared value = 52.95, P-value = 8.71e-11 (highly significant)

BV Clear on discharge effect chart.JPG

  • NeuEve BV Clear (Recommended for Ages Under 45) - Itching/burning
    • Participants: N = 253
    • Before Treatment: 8.7% very severe, 9.9% severe, 21.7% moderate, 20.2% slight, 39.5.9% no itching/burning
    • After Treatment: 5.1% very severe, 4.7% severe, 9.9% moderate, 22.1% slight, 58.1% no itching/burning
    • Statistical Analysis: Chi-squared value = 27.39, P-value = 1.65 × 10⁻⁵ (highly significant)

BV Clear on itching and burning effect chart.JPG

  • NeuEve AV NIL
    • Participants: N = 18
    • Before Treatment: 44.4% very severe, 38.9% severe, 11.1% moderate, 5.6% slight, 0.0% no symptoms
    • After Treatment: 5.6% very severe, 5.6% severe, 22.2% moderate, 38.9% slight, 27.8% no symptoms
    • Statistical Analysis: Chi-squared value = 20.06, P-value = 0.00049 (highly significant)

AV Clear Effect Chart.JPG

Conclusion:

The survey results reflect outcomes after one month of NeuEve use. With continued application, nearly all customers—including those with severe vaginal dryness from pelvic radiation or superbug infections unresponsive to estrogen or antibiotics—experienced full relief. These results underscore NeuEve’s effectiveness in easing vaginal dryness and restoring microbial balance.

Pelvic radiation therapy often causes the most severe vaginal atrophy due to its damaging effects. In such cases, both estrogen and laser treatments have frequently failed to help. However, physicians at the renowned Massachusetts General Hospital (Harvard University, Boston) observed that NeuEve provided significant, lasting relief for their radiation-treated patients. As a result, NeuEve is now recognized as one of the most effective natural, hormone-free solutions for vaginal dryness and atrophy.

May 20, 2025

Contact Us

Not finding what you're looking for? Contact Us Directly